Search

Your search keyword '"Cepika, Alma"' showing total 149 results

Search Constraints

Start Over You searched for: Author "Cepika, Alma" Remove constraint Author: "Cepika, Alma"
149 results on '"Cepika, Alma"'

Search Results

3. Therapeutics and Diagnostics Discovery

6. Correction to: Therapeutics and Diagnostics Discovery

7. Epigenetic signature and key transcriptional regulators of human antigen-specific type 1 regulatory T cells

8. Enhanced Immune Reconstitution and Reduced GvHD Risk with T-allo10 Infusion Post Aβdepleted-HSCT in Pediatric and Young Adult Patients with Hematologic Malignancies

10. Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape

11. Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients

12. Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition.

13. Data from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer

14. Table S4 from IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer

15. SATB1ss Chromatin Loops Regulate Megakaryocyte/Erythroid Progenitor Expansion by Facilitating HSP70 and GATA1 Induction

16. Toll-like receptors in pathogenesis of systemic lupus erythematosus

17. T-allo10 Infusion after αβ depleted-HSCT in Children and Young Adults with Hematologic Malignancies: Improved Immune Reconstitution in the Absence of Severe GvHD

19. Systems Scale Interactive Exploration Reveals Quantitative and Qualitative Differences in Response to Influenza and Pneumococcal Vaccines

21. Phase 1/1b Study of T-allo10 Infusion after HLA-Partially Matched αβ depleted-HSCT in Children and Young Adults with Hematologic Malignancies: Preliminary Results

22. Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients

23. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency

24. BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation

25. 146 Alloantigen-specific Tr1 cells designed to prevent GvHD have a distinct molecular identity and suppress through CTLA-4 and PD-1

26. Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells

32. Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy

33. IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer

34. A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis

36. Učinak montelukasta na regulacijske T-limfocite i imunoregulacijske citokine u djece s alergijskom astmom

37. Circulating early plasma cells with high TLR9 and low BAFF-receptor expression in a SLE patient before and after treatment

38. Monocyte response to LPS after exposure to corticosteroids and chloroquine with implications for systemic lupus erythematosus

39. Multi-color phenotyping of FOXP3 and IL-7 receptor-alpha levels on human CD4+CD25high regulatory T cells

40. Conventional treatment modulates B cell TLR9 expresssion and IL-10 and BAFF production in systemic lupus erythematosus

41. Razlike u ekspresiji TLR9 i produkciji interleukina-10 i BAFF-a u novootkrivenih bolesnika sa sistemskim eritemskim lupusom tijekom liječenja klorokinom

42. Circulating B-cell activating factor levels' dependence on treatment in patients with systemic lupus erythematosus

43. Effect of chloroquine add-on therapy on TLR9 expression in systemic lupus erythematosus

44. Immunomodulatory therapy, B cells and autoimmune disease

45. Alternative to animal testing: new approaches in the development and control of biologicals

46. Modulation of Toll-like receptor 9 expression in systemic lupus erythematosus

47. Effect of steroid on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up

48. Extracellular expression of otherwise intracellular Toll-like receptors

50. THE ROLE OF TOLL-LIKE RECEPTORS AND REGULATORY T CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Catalog

Books, media, physical & digital resources